D A Kelly
YOU?
Author Swipe
View article: Reduced Presentation of Biliary Atresia During the COVID‐19 Lockdown
Reduced Presentation of Biliary Atresia During the COVID‐19 Lockdown Open
Objective: The aim of this study was to assess whether there has been a change in presentations of biliary atresia (BA) in England and Wales during the first and second coronavirus disease 2019 (COVID‐19) lockdowns (January–June 2020 and 2…
View article: Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection
Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection Open
Currently, the only approved hepatitis C virus (HCV) treatment for children aged <12 years is pegylated interferon plus ribavirin. In an open‐label study, we evaluated the safety and efficacy of sofosbuvir plus ribavirin for 12 weeks in ch…